BioxyneASX:BXNDA -2.06%50 Net Margin % is 23.45% as of Dec. 2025. GuruFocus rates ASX:BXNDA with a GF Score™ of 50/100 and a GF Value™ of A$0.69 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 1,952 Consumer Packaged Goods companies, Bioxyne ranks better than 92.73% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Bioxyne's Net Income for the
six
months ended in Dec. 2025 was A$7.34 Mil. Bioxyne's Revenue for the
six
months ended in Dec. 2025 was A$31.31 Mil. Therefore, Bioxyne's net margin for the quarter that ended in Dec. 2025 was 23.45%.
The historical rank and industry rank for Bioxyne's Net Margin % or its related term are showing as below:
ASX:BXNDA'
s Net Margin % Range Over the Past 10 Years
Min: -142.9 Med: -32.15 Max: 19.01
Current: 19.01
ASX:BXNDA's Net Margin % is ranked better than 92.73% of 1952
companies
in the Consumer Packaged Goods industry
Industry Median: 3.495
vs ASX:BXNDA: 19.01
Bioxyne (ASX:BXNDA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Bioxyne Net Margin % Related Terms
Bioxyne Net Margin % Historical Data
* Premium members only.
The historical data trend for Bioxyne's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Bioxyne's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioxyne Net Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioxyne's Net Margin % distribution charts can be found below:
* The bar in red indicates where Bioxyne's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioxyne (ASX:BXNDA) has a Net Margin % of 23.45% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Bioxyne and its competitors. According to the industry distribution chart, Bioxyne ranks #142 out of 1952 companies in the Consumer Packaged Goods industry, placing it in the top 7.3%.
Is Bioxyne's Net Margin % too high?
Bioxyne's current Net Margin % is 23.45%. The Consumer Packaged Goods industry median Net Margin % is 3.50. Bioxyne's value of 23.45% is 571% above this industry median. Based on the distribution chart, Bioxyne ranks #142 out of 1952 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Bioxyne has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bioxyne's Net Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioxyne ranks #142 out of 1952 companies for Net Margin %. This places Bioxyne in the top 7% of its industry — outperforming the majority of peers. The industry median Net Margin % is 3.50. Bioxyne's value of 23.45% is 571% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Consumer Packaged Goods company?
The median Net Margin % among Consumer Packaged Goods companies is 3.50, based on 1,952 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioxyne's current Net Margin % of 23.45% is 571% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Bioxyne and its competitors. For the Consumer Packaged Goods industry, the median Net Margin % is 3.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioxyne's current Net Margin % is 23.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioxyne stock overvalued right now?
Based on GuruFocus' analysis, Bioxyne (ASX:BXNDA) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.69, compared to a current price of A$0.95 — trading 37.7% above its estimated fair value. The current Net Margin % is 23.45% and 571% above the Consumer Packaged Goods industry median of 3.50. Bioxyne's overall GF Score™ is 50/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Bioxyne (ASX:BXNDA), the current Net Margin % is 23.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioxyne (ASX:BXNDA) Overvalued in 2026?
Based on GuruFocus' analysis, Bioxyne stock appears to be overvalued.
The current stock price of A$0.95 is trading 37.7% above its estimated GF Value™ of A$0.69.
GuruFocus considers Bioxyne to be Significantly Overvalued.
Key valuation signals for ASX:BXNDA:
Net Margin %: 23.45%
GF Value™: A$0.69 vs. price of A$0.95 (37.7% above fair value)
Industry Position: 571% above the Consumer Packaged Goods median (#142 of 1952)
No single metric tells the full story. See the ASX:BXNDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments, namely, Pharmaceutical manufacture and wholesale supply (business to business), Manufacture and distribution (wholesale, online, and retail), and Wholesale of patented Probiotics.
50GF Score
Get the complete analysis for ASX:BXNDA
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BXNDA has been successfully added to your 
